dyspnea tightness of the chest
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Research group: - Children from 0 months to 6 years who present with acute shortness of breath and treated with Sabutamol (sometimes combined with Ipratropium bromide). ;control group: - Children from 0 months to 6 years - From a nursery, after school care or school in the province of Groningen and Drenthe
Exclusion criteria
Exclusion criteria: research group: - Congenital disorders that can cause distress and severe congenital heart disease or cystic fibrosis. - Status after diaphragmatic hernia - Allergy to EMG patches - Prematurity - Pneumonia ;control group: - Congenital disorders or acquired diseases that can cause distress and severe congenital heart defects, cystic fibrosis, asthma, pneumonia. - Use of bronchodilator agents - Status after diaphragmatic hernia - Allergy to EMG patches - Prematurity
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The main data obtained in this study are the EMG values **before and after treatment with Salbutamol in children with acute dyspnea. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcome measure is the degree of dyspnea. This consists of the Clinical Asthma Score, determined by the investigator, and the Borg scale, determined by the parents. Beside, EMG values **of acutely distressed children will be compared with EMG values **in healthy peers. | — |
Countries
Netherlands